Stockreport

Competitive Landscape of Obesity Therapeutics Market Enters High-Growth Phase, Fueled by GLP-1 Surge and Expanding Oral Treatments | DataM Intelligence [Yahoo! Finance]

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of)  (TAK) 
PDF Although precise market size figures for this report were not publicly disclosed in full, broader indicators show the weight-loss/obesity therapeutics subset rising from [Read more]